U.S. flag

An official website of the United States government

NM_153766.3(KCNJ1):c.602T>G (p.Leu201Arg) AND Bartter disease type 2

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jul 1, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001089940.2

Allele description [Variation Report for NM_153766.3(KCNJ1):c.602T>G (p.Leu201Arg)]

NM_153766.3(KCNJ1):c.602T>G (p.Leu201Arg)

Gene:
KCNJ1:potassium inwardly rectifying channel subfamily J member 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q24.3
Genomic location:
Preferred name:
NM_153766.3(KCNJ1):c.602T>G (p.Leu201Arg)
HGVS:
  • NC_000011.10:g.128839642A>C
  • NG_009379.1:g.32732T>G
  • NM_000220.6:c.659T>G
  • NM_153764.3:c.602T>G
  • NM_153765.3:c.653T>G
  • NM_153766.3:c.602T>GMANE SELECT
  • NM_153767.4:c.602T>G
  • NP_000211.1:p.Leu220Arg
  • NP_722448.1:p.Leu201Arg
  • NP_722449.3:p.Leu218Arg
  • NP_722450.1:p.Leu201Arg
  • NP_722451.1:p.Leu201Arg
  • NC_000011.9:g.128709537A>C
  • NM_000220.4:c.659T>G
Protein change:
L201R
Links:
dbSNP: rs1411280373
NCBI 1000 Genomes Browser:
rs1411280373
Molecular consequence:
  • NM_000220.6:c.659T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_153764.3:c.602T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_153765.3:c.653T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_153766.3:c.602T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_153767.4:c.602T>G - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Bartter disease type 2
Synonyms:
HYPOKALEMIC ALKALOSIS WITH HYPERCALCIURIA 2, ANTENATAL; Hyperprostaglandin E syndrome 2; Bartter syndrome, type 2, antenatal
Identifiers:
MONDO: MONDO:0009424; MedGen: C1855849; Orphanet: 112; OMIM: 241200

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001244984Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Jul 1, 2018)
maternalclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedmaternalyes21not providednot providedyesclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Victorian Clinical Genetics Services, Murdoch Childrens Research Institute, SCV001244984.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided2not providedyesclinical testing PubMed (1)

Description

A heterozygous missense variant, NM_000220.4(KCNJ1):c.659T>G, has been identified in exon 2 of 2 of the KCNJ1 gene (NB: This gene is also known as Kir1.1). The variant is predicted to result in a major amino acid change from a leucine to an arginine at position 220 of the protein, NP_000211.1(KCNJ1):p.(Leu220Arg). The leucine residue at this position has very high conservation (100 vertebrates, UCSC), and is located within the IRK potassium channel domain. In silico predictions for this variant are consistently pathogenic (Polyphen, SIFT, CADD, Mutation Taster). The variant is present in the gnomAD database at a frequency of 0.00041% (1 heterozygote, 0 homozygote). An alternate change within the same residue, p.(Leu220Phe) was also present in gnomAD at a frequency of 0.037% (89 heterozygotes, 0 homozygotes). This variant has not been previously reported in clinical cases. However, a different variant in the same codon resulting in a change to a phenylalanine, p.(Leu220Phe) have been observed as a compound heterozygote with a second missense variant in two families with Barrter syndrome (Vollmer, M., et al. (1998), Srivastava, S., et al. (2013)). Analysis of parental samples indicated this variant was maternally inherited. Based on the information available at the time of curation, this variant has been classified as LIKELY PATHOGENIC.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1maternalyesnot providednot providednot provided2not provided1not provided

Last Updated: Jan 15, 2023